Breast cancer in Mexico: a growing challenge to health and the health system

Farmer, 2010, Expansion of cancer care and control in countries of low and middle income: a call to action, Lancet, 376, 1186, 10.1016/S0140-6736(10)61152-X

Knaul

Forouzanfar, 2011, Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis, Lancet, 378, 1461, 10.1016/S0140-6736(11)61351-2

Palacio-Mejia, 2009, Regional differences in breast and cervical cáncer mortality in Mexico between 1979–2006, Salud Publica Mex, 51, s208

Knaul, 2008, Breast cancer in Mexico: a pressing priority, Reprod Health Matters, 16, 113, 10.1016/S0968-8080(08)32414-8

Anderson, 2011, Optimisation of breast cancer management in low-resource and middle-resource countries: executive summary of the Breast Health Global Initiative consensus, 2010, Lancet Oncol, 12, 387, 10.1016/S1470-2045(11)70031-6

Lee, 2012, Breast cancer in Brazil: present status and future goals, Lancet Oncol, 13, e95, 10.1016/S1470-2045(11)70323-0

Franci-Marina, 2009, Breast cancer mortality in Mexico. An age-period-cohort analysis, Salud Publica Mex, 51, s157, 10.1590/S0036-36342009000800005

Berry, 2005, Effect of screening and adjuvant therapy on mortality from breast cancer, N Engl J Med, 353, 1784, 10.1056/NEJMoa050518

2009, Screening for breast cancer: US Preventive Services Task Force recommendation statement, Ann Intern Med, 151, 716, 10.7326/0003-4819-151-10-200911170-00008

Martinez-Montanez, 2009, Public policies for the detection of breast cancer in Mexico, Salud Publica Mex, 51, S350

Olaiz-Fernández

Sosa-Rubí, 2009, Performance of mammography and Papanicolau among rural women in Mexico, Salud Publica Mex, 51, s236, 10.1590/S0036-36342009000800014

Liao, 2011, Surveillance of health status in minority communities—racial and ethnic approaches to community health across the US (REACH US) risk factor survey, United States, 2009, MMWR Surveill Summ, 60, 1

Valencia-Mendoza, 2009, Cost-effectiveness of breast cancer screening policies in Mexico, Salud Publica Mex, 51, s296, 10.1590/S0036-36342009000800020

Knaul, 2009, The health care costs of breast cancer: the case of the Mexican Social Security Institute, Salud Publica Mex, 51, s286, 10.1590/S0036-36342009000800019

Villarreal-Garza, 2010, Knowledge about cancer screening among medical students and internal medicine resident in Mexico City, J Canc Educ, 25, 624, 10.1007/s13187-010-0098-6

Ortiz Mendoza, 2007, Reproductive risk factors for breast cancer patients treated at an urban hospital in second level, Ginecol Obstet Mex, 75, 11

Tovar-Guzman, 2000, Breast cancer in Mexican women: an epidemiological study with cervical cancer control, Salud Publica Mex, 34, 112

Romieu, 1996, Breast cancer and lactation history in Mexican women, Am J Epidemiol, 143, 543, 10.1093/oxfordjournals.aje.a008784

Lopez-Carrillo, 1997, Reproductive determinants of breast cancer in Mexican Women, Ann NY Acad Sci, 837, 537, 10.1111/j.1749-6632.1997.tb56898.x

Sánchez-Zamorano, 2011, Healthy lifestyle on the risk of breast cancer, Cancer Epidemiol Biomarkers Prev, 20, 912, 10.1158/1055-9965.EPI-10-1036

Franco-Marina F, Lozano R, Villa B, Soliz P. Mortality in Mexico, 2000–2004: preventable deaths: extent, distribution and trends. Mexico, DF: Secretaria de Salud, 2006 (in Spanish).

Ortiz-Rodriguez, 2008, Physical activity and breast cancer risk in Mexican women, Salud Publica Mex, 50, 126

Torres-Sanchez, 2009, Diet and breast cancer in Latin-America, Salud Publica Mex, 51, s181

Lara-Medina, 2011, Triple-negative breast cancer in Hispanic patients: high prevalence, poor prognosis, and association with menopausal status, body mass index, and parity, Cancer, 117, 3658, 10.1002/cncr.25961

Narod, 2009, Screening for BRCA1 and BRCA2 mutations in breast cancer patients from Mexico: the public health perspective, Salud Publica Mex, 51, s191, 10.1590/S0036-36342009000800009

Calderon-Garciduenas, 2005, Clinical follow up of Mexican women with early onset of breast cancer and mutations in the BRCA1 and BRCA2 genes, Salud Publica Mex, 47, 110, 10.1590/S0036-36342005000200004

Fejerman L, Romieu I, John EM, et al. European ancestry associated with breast cancer risk in Mexican women. Cancer Epidemiol Biomarkers Prev; 19: 1074–82.

Medina-Franco, 2004, Risk of invasive breast cancer in Mexican population and patterns of screening and prophylaxis, Rev Invest Clin, 56, 422

Fisher, 1998, Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study, J Natl Cancer Inst, 90, 1371, 10.1093/jnci/90.18.1371

Goss, 2011, Exemestane for breast-cancer prevention in postmenopausal women, N Engl J Med, 364, 2381, 10.1056/NEJMoa1103507

Sánchez

Shulman, 2010, Breast cancer in developing countries: opportunities for improved survival, J Oncol, 2010, 595167, 10.1155/2010/595167

Lopez-Carrillo, 2001, Identification of malignant breast lesions in Mexico, Salud Publica Mex, 43, 199

Mohar, 2009, Available resources for the treatment of breast cancer in Mexico, Salud Publica Mex, 51, s263

Nigenda, 2009, Access barriers in early diagnosis of breast cancer in the Federal District and Oaxaca, Salud Publica Mex, 51, s254

Bright, 2011, The role of health system factors in delaying final diagnosis and treatment of breast cancer in Mexico City, Mexico, Breast, 20, s54, 10.1016/j.breast.2011.02.012

Unger-Saldana, 2009, Delay of medical care for symptomatic breast cancer: a literature review, Salud Publica Mex, 51, s270, 10.1590/S0036-36342009000800018

Rodriguez-Cuevas, 2001, Breast carcinoma presents a decade earlier in Mexican women than in women in the United States or European countries, Cancer, 91, 863, 10.1002/1097-0142(20010215)91:4<863::AID-CNCR1074>3.0.CO;2-Y

Kouri, 2010, Influence of birthplace on breast cancer diagnosis and treatment for Hispanic women, Breast Cancer Res Treat, 121, 743, 10.1007/s10549-009-0643-3

Arce-Salinas, 2012, Evaluation of treatment of breast cancer in a tertiary level with the Seguro Popular, Mexico, Rev Invest Clin, 64, 9

Willems, 2012, Diagnosis of breast lesions: fine-needle aspiration cytology or core needle biopsy? A review, J Clin Pathol, 65, 287, 10.1136/jclinpath-2011-200410

Medina-Franco, 2005, Fine needle aspiration biopsy of breast lesions: institutional experience, Rev Invest Clin, 57, 394

Carrillo, 1999, Accuracy of combined clinical findings and fine needle aspiration cytology for the diagnosis in palpable breast tumors, Rev Invest Clin, 51, 333

Liedtke, 2008, Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer, J Clin Oncol, 26, 1275, 10.1200/JCO.2007.14.4147

Patel, 2010, Breast cancer in Latinas: gene expression, differential response to treatments, and differential toxicities in Latinas compared with other population groups, Oncologist, 15, 466, 10.1634/theoncologist.2010-0004

Bargallo-Rocha JE, Lara F, Shawn Dulin RJ, et al. A study of impact of the 21-gene breast cancer assay on the use of adjuvant chemotherapy in women with breast cancer in a Mexican public hospital. ESMO 2012–37th European Society for Medical Oncology Congress; Vienna, Austria; Sept 28–Oct 2, 2012. 2126.

Gomez Dantes, 2011, The health system of Mexico, Salud Publica Mex, 53, S220

Jatoi, 2005, Randomized trials of breast-conserving therapy versus mastectomy for primary breast cancer. A pooled analysis of updated results, Am J Clin Oncol, 28, 289, 10.1097/01.coc.0000156922.58631.d7

Habermann, 2010, Are mastectomy rates really increasing in the United States?, J Clin Oncol, 28, 3437, 10.1200/JCO.2009.27.6774

Meric, 2003, Positive surgical margins and ipsilateral breast tumor recurrence predict disease-specific survival after breast-conserving therapy, Cancer, 97, 926, 10.1002/cncr.11222

Veronesi, 2010, Sentinel lymph node biopsy in breast cancer. ten-year results of a randomized controlled study, Ann Surg, 251, 595, 10.1097/SLA.0b013e3181c0e92a

Vergara-Fernandez, 2004, Validation of sentinel node in breast cancer, Rev Invest Clin, 56, 309

Gallegos-Hernandez, 2003, Lymphatic mapping and sentinel lymph node biopsy in patients with breast cancer, Gac Med Mex, 139, 205

Zarco Espinosa, 2009, Recommendations in metastatic breast cancer, GAMO, 8, 1

Torres Vigil, 2007, What predicts the quality of advanced cancer care in Latin America? A look at five countries: Argentina, Brazil, Cuba, Mexico and Peru, J Pain Symptom Manage, 34, 315, 10.1016/j.jpainsymman.2006.11.015

Cazap, 2008, Breast cancer in Latin America. Results of the Latin American and Caribbean Society of Medical Oncology/Breast Cancer Research Foundation Expert Survey, Cancer, 113, 2359, 10.1002/cncr.23834

Chavarri-Guerra Y, Liedke PER, Symecko H, et al. 34th Annual San Antonio Breast Cancer Symposium (SABCS); San Antonio, Texas; Dec 6–10, 2011. P1-11-12.

ClinicalTrials.gov. www.clinicaltrials.gov. 2012 (accessed Jan 25, 2012).

Maza-Fernandez, 2009, History, overview and challenges of the breast cancer movement in Mexico, Salud Publica Mex, 51, s329

Knaul